% | $
Quotes you view appear here for quick access.

Synergy Pharmaceuticals, Inc. Message Board

  • biotech_venture_capitalist biotech_venture_capitalist Mar 20, 2013 1:51 PM Flag

    The big deal with SCMP is that they just won approval for their CIC drug in Japan, and Abbott is the partner there, AND Sucampo will

    sell the drug directly to Abbott at a whole sale price. This means that they will book revenues directly, at lets say 80%. This is much better than the 18% royalties from Takeda in the US. Japan is the second most prescribing country in the world. This is a huge market

4.01-0.10(-2.43%)Apr 24 4:00 PMEDT